Q3 2022
Released Nov 2, 2022, after the close
10-Q filed Nov 3, 2022, 34 days after period end · 0001653477-22-000042
Q3 2022 · 10-Q
Revenue$482.00M$482.00M +27.9% vs Q3 2021+14.8% vs Q2 2022
Net Income$75.40M$75.40M N/M vs Q3 2021+26.1% vs Q2 2022
EPS Diluted$1.98$1.98 N/M vs Q3 2021+28.6% vs Q2 2022
Gross Profit$176,300,000+24.3%
Operating Income$138,200,000+15.6%
Operating Cash Flowderived$100,100,000±0.0%
Free Cash Flowderived$64,000,000−14.2%
Margins · derived
Gross margin36.6%−1.1 pt vs Q3 2021
Operating margin28.7%−3.0 pt vs Q3 2021
Net margin15.6%+16.8 pt vs Q3 2021
What the release said
The release
Same quarter
| Metric | Q3 2022 | Q3 2021 | Q3 2020 | Q3 2019 |
|---|---|---|---|---|
| Revenue | $482.00M | $376.80M | $331.70M | $359.90M |
| Net Income | $75.40M | -$4.20M | $69.90M | $59.90M |
| EPS Diluted | $1.98 | -$0.11 | $1.69 | $1.41 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ingevity Corp · CIK 1653477 · Engraved from SEC EDGAR